INS and Insulin resistance: As anticipated and compared with nondiabetics, T2D patients not only reflected insulin resistance as indicated by their elevated fasting glucose (p < 0.0001), insulin (p = 0.0006), and homeostatic model assessment of insulin resistance (HOMA-IR) (p = 0.042 but also had significantly high levels of triglycerides (p < 0.0001), a common marker of patients with uncontrolled T2D [32].